Orlistat 60 mg reduces visceral adipose tissue: a 24-week randomized, placebo-controlled, multicenter trial.

Title: Orlistat 60 mg reduces visceral adipose tissue: a 24-week randomized, placebo-controlled, multicenter trial.

Source: Obesity, 2011, 19 (9) p.1796-1803.

Follow this link for abstract.

Date of publication: September, 2011.

Publication type: Research.

In a nutshell: This study examines the effects of a 24-week weight loss program with Orlistat 60mg upon participants’ visceral adipose tissue (VAT) in comparison with placebo.  Whilst all participants had significantly reduced their VAT, those taking Orlistat also displayed a greater total fat mass loss and reduction in their intramuscular adipose tissue and liver fat content.  These results suggest that Orlistat 60mg may be an effective weight loss tool, particularly in relation to abdominal obesity.

Length of publication: 8 pages.

Some important notes: Please contact your local NHS Library for the full text of the article. Follow this link to find your local NHS Library.

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: